Zoya Technologies launches ZoyeMed 3.0 edge-based clinical system at WHX Dubai

Zoya Technologies has announced the launch of ZoyeMed 3.0, an edge-native clinical terminal intended to support primary and acute care delivery with human oversight. The system was unveiled at WHX Dubai 2026 and combines on-device artificial intelligence, multimodal sensors, point-of-care testing, and longitudinal patient data to enable diagnostic support without continuous reliance on cloud connectivity.

According to the company, ZoyeMed 3.0 marks a shift from earlier versions of the platform. Previous iterations focused on integrating multiple clinical sensors, while the new version adopts a closed-loop, edge-first architecture that separates real-time safety and triage functions from more advanced analytical processes. Zoya Technologies says this design is aimed at maintaining functionality in settings with limited bandwidth, staffing shortages, or intermittent internet access, while allowing patient data to be modelled over time.

Since 2025, the company has deployed 44 ZoyeMed 1.0 units. Deployments are currently underway in Mexico under a multi-phase agreement covering up to 300 units. In Colombia, Zoya Technologies has signed contracts for the delivery of 64 units per year over a three-year period. The first ZoyeMed 3.0 unit has been delivered to Bogotá ahead of a planned pilot programme following its presentation in Dubai.

Zoya Technologies positions ZoyeMed 3.0 as a standalone clinical infrastructure system rather than a software layer added to existing hospital platforms. The unit integrates diagnostics, clinical decision support, and follow-up processes into a single on-site system, with the stated aim of supporting clinicians and expanding access to standardised care.